Answers are grounded in this paper and cite their sources.
Summary Screening experiments with 30 selected purine and pyrimidine analogues have revealed five compounds which inhibited hemagglutinin production in mice. Of these, 6-mercaptopurine, 6-mercaptopurine riboside, 2-amino-6-benzylmercaptopurine and 2-amino-6-(1′-methyl-4′-nitroso-5′-imidazoyl) mercaptopurine were classed as slightly active. One of the compounds, thioguanine, was found to be highly active in toxic doses. 6-mercaptopurine did not inhibit hemagglutinin formation in rabbits given a dose of 6 mg/kg for 13 days when either human or sheep red blood cells were used as antigen. In groups of mice also, 6-MP, at a dose level of 25 mg/kg, failed to prevent hemagglutinin formation. Thioguanine, however, in doses of 5 and 2.5 mg/kg, but not 1 mg/kg, blocked primary hemagglutinin production. With single animals, the inhibiting effect of thioguanine was uniformly evident; with 6-MP, variations were observed among individual mice. The data are discussed in relation to previously published studies on 6-MP.
No takes yet. Share an insight, caveat, or question.
Frisch et al. (1962) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: